Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis

Neuroscience Letters

Volumn 380, Issue 1-2, 2005, Pages 122-126

  Blanco, Y ^a,b   Saiz, A ^a,b   Costa, M ^c   Torres Peraza, J F ^b   Carreras, E ^a,b   Alberch, J ^b   Jaraquemada, D ^c   Graus, F ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

BDNF; Cytokines; Hematopoietic stem cell transplantation; Lymphocyte immunophenotyping; Multiple sclerosis

Indexed keywords

ANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; CD28 ANTIGEN; CD3 ANTIGEN;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN ATROPHY; CELL CULTURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DOWN REGULATION; FOLLOW UP; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 18044398996     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.01.032     Document Type: Article

References (17)

1. R.F. Alderson, A.L. Alterman, Y.A. Barde, and R.M. Lindsay Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture Neuron 5 1990 297 306
2. Y. Blanco, A. Saiz, E. Carreras, and F. Graus Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis J. Neuroimmunol. 153 2004 190 194
3. E. Carreras, A. Saiz, P. Marin, C. Martinez, M. Rovira, N. Villamor, M. Aymerich, M. Lozano, F. Fernandez-Aviles, A. Urbano-Izpizua, E. Montserrat, and F. Graus CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients Haematologica 88 2003 306 314
4. R. Chen, L. Lowe, J.D. Wilson, E. Crowther, K. Tzeggai, J.E. Bishop, and R. Varro Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology Clin. Chem. 9 1999 1693 1694
5. H. Hammarberg, O. Lidman, C. Lundberg, S.Y. Eltayeb, A.W. Gielen, S. Muhallab, A. Svenningsson, H. Linda, P.H. van Der Meide, S. Cullheim, T. Olsson, and F. Piehl Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells J. Neurosci. 20 2000 5283 5291
6. R. Hohlfeld, M. Kerschensteiner, C. Stadelmann, H. Lassmann, and H. Wekerle The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis J. Neuroimmunol. 107 2000 161 166
7. M. Kerschensteiner, E. Gallmeier, L. Behrens, V.V. Leal, T. Misgeld, W.E. Klinkert, R. Kolbeck, E. Hoppe, R.L. Oropeza-Wekerle, I. Bartke, C. Stadelmann, H. Lassmann, H. Wekerle, and R. Hohlfeld Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189 1999 865 870
8. D. Leppert, E. Waubant, R. Galardy, N.W. Bunnett, and S.L. Hauser T cell gelatinases mediate basement membrane transmigration in vitro J. Immunol. 154 1995 4379 4389
9. D.M. McTigue, P.J. Horner, B.T. Stokes, and F.H. Gage Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord J. Neurosci. 18 1998 5354 5365
10. D.W. Paty, and H. McFarland Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials J. Neurol. Neurosurg. Psychiatry 64 1998 S47 S51
11. E. Perez-Navarro, A.M. Canudas, P. Akerund, J. Alberch, and E. Arenas Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease J. Neurochem. 75 2000 2190 2199
12. E.L. Reinherz, S. Meuer, K.A. Fitzgerald, R.E. Hussey, H. Levine, and S.F. Schlossman Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex Cell 30 1982 735 743
13. R.D. Rosenfeld, L. Zeni, M. Haniu, J. Talvenheimo, S.F. Radka, L. Bennett, J.A. Miller, and A.A. Welcher Purification and identification of brain-derived neurotrophic factor from human serum Protein Expr. Purif. 6 1995 465 471
14. A. Saiz, Y. Blanco, E. Carreras, J. Berenguer, M. Rovira, T. Pujol, P. Marin, T. Arbizu, F. Graus, and Clinical MRI outcome after autologous hematopoietic stem cell transplantation in MS Neurology 62 2004 282 284
15. P. Sarchielli, L. Greco, A. Stipa, A. Floridi, and V. Gallai Brain-derived neurotrophic factor in patients with multiple sclerosis J. Neuroimmunol. 132 2002 180 188
16. C. Stadelmann, M. Kerschensteiner, T. Misgeld, W. Bruck, R. Hohlfeld, and H. Lassmann BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125 2002 75 85
17. H. Yamamoto, and M.E. Gurney Human platelets contain brain-derived neurotrophic factor J. Neurosci. 10 1990 3469 3478